Mitochondria

Mitochondria are compartments inside cells that burn fuel with oxygen. Main fuels: glucose (blood sugar) and fatty acids. Products: energy as ATP, water, and carbon dioxide (CO₂).

High ATP per unit of fuel with steady CO₂ marks metabolic health. Barrier function and vessel integrity rest on that energy.

Cellular energy metabolism is the basis for maintaining the barrier functions. Energy depletion causes the endothelial cells lining blood vessels to become excessively permeable.

— Ray Peat

Cytochrome oxidase and red light

Cytochrome c oxidase (complex IV) is the step that hands electrons to oxygen. It is sensitive to thyroid status. Inhibitors include nitric oxide, carbon monoxide, estrogen, PUFA, serotonin, excess iron, ionizing radiation, and bacterial endotoxin. Red and orange wavelengths reach the enzyme through tissue because water absorbs them weakly, raising ATP. Red light reactivates the enzyme in the same literature line.

Estrogen impairs the mitochondria in multiple ways, including blocking the function of cytochrome oxidase, decreasing the activity of ATP synthase, increasing heme oxygenase which produces carbon monoxide and free iron, damaging mitochondrial DNA, and shifting metabolism from glucose oxidation to fat oxidation, especially by inhibiting pyruvate dehydrogenase complex.

— Ray Peat

Pyruvate dehydrogenase is the gate that feeds sugar fragments into full aerobic burning. Blocking it pushes fat use and lactate.

Efficient burn vs stress burn

Uncoupling oxidative metabolism from ATP production helps burn sugar that would otherwise become lactic acid, turning it into carbon dioxide instead.

Efficient pattern: glucose → CO₂ + water + ATP. Marks: solid thyroid, low PUFA load, low endotoxin.

Stress pattern: glycolysis (sugar split) → lactic acid even at rest. Marks: high cortisol and adrenaline, free fatty acids, estrogen, serotonin. See Randle cycle and Free fatty acids.

Aspirin shifts mitochondria toward glucose oxidation and stimulates respiration (see Aspirin). Thyroid hormone and progesterone support oxidative metabolism.

CO₂ from the burn

CO₂ from steady respiration is protective structure. It links to the Bohr effect (oxygen delivery into tissues), vessel tone, and mast-cell stability. Hyperventilation lowers CO₂ and raises serotonin and histamine release. In a 2025 hypothesis paper, declining mitochondrial CO2 output weakens the Bohr effect and oxygen delivery, and that the resulting hypoxia (via HIF-1) further suppresses mitochondrial function, forming a self-reinforcing "aging spiral" reversible only until intracellular energy falls below the threshold needed for cell division. See CO2.

Impair and support

In heart mitochondria, arachidonic acid inhibited Complexes I and III and sharply raised hydrogen peroxide production, and unsaturated fatty acids inhibited respiration more than saturated ones.

Impair: endotoxin / TLR4 activation (nitric oxide, cytokines), PUFA (lipid peroxidation, cardiolipin damage), hypothyroidism, serotonin.

Support: glucose, salt, gelatin/glycine, niacinamide, coffee, thyroid, progesterone, CO₂ retention, red light. Low-dose methylene blue is experimental; see Harm reduction.

High-concentration SSRIs (escitalopram, fluvoxamine, sertraline, paroxetine), and to a lesser extent trazodone and bupropion, inhibit ETC complexes I and IV and reduce complex I-linked respiration in isolated pig brain mitochondria; complex II-linked respiration fell only with bupropion. The same drugs inhibit MAO-A and MAO-B, with SSRIs stronger than trazodone or bupropion.

Mitochondrial failure pushes immune cells and bone-resorbing cells into harmful states in modern work: T-cell exhaustion via HIF-1α glycolysis; osteoclast drive when complex IV fails; gut lipid export fails when enterocyte mitochondria fail. Chronic psychological stress tracks lower oxidative-phosphorylation proteins in human brain glia, complex I hardest hit.

ATP synthase as K⁺ entry path

ATP synthase can act as the main mitochondrial K⁺ “uniporter”: K⁺ entry scales with ATP synthesis and helps match matrix volume to energy supply and demand. Bcl-xL and Mcl-1 (but not Bcl-2) engage IF1 at a conserved BH3-like domain and upregulate the synthase’s H⁺ and K⁺ fluxes and ATP synthesis in that framework.

Mitochondrial disease and antiviral immunity

Children with primary mitochondrial disease showed impaired humoral immunity: less robust and less diverse antiviral antibody responses than healthy controls despite similar viral exposure, alongside selective depletion of the B cells and antigen-presenting cells that produce those antibodies. Low mitochondrial function functions like a form of immunosuppression.

Electron flow, not ATP, governs immune readiness

Dendritic cells are kept in a "ready to respond" state not by ATP levels but by the speed of electron flow through the mitochondrial respiratory chain. Restoring electron flow with an alternative oxidase (AOX), without increasing ATP production, recovered dendritic cells' ability to activate T cells and control tumor growth in mice; disrupting electron flow impaired activation, lymph-node migration, and anti-tumor immunity.

Gulf War illness as mitochondrial hypofunction

Magnetic resonance spectroscopy in Persian Gulf War veterans with Gulf War illness found a lower NAA/creatine ratio driven by elevated total creatine, not by reduced NAA -- pointing to mitochondrial dysfunction and impaired ATP production rather than neuron loss as the underlying cause of a condition long dismissed as unexplained or psychogenic. A small trial of CoQ10 produced modest improvement, though at doses (100-300 mg) well below what other severe mitochondrial-dysfunction conditions have required.

Oral contraceptives and liver mitochondria

Long-term oral contraceptive use (12 to 30 months) produced liver mitochondrial shape change, enlargement, and crystalline inclusions on electron microscopy; shorter use (1 to 6 months) mainly increased smooth endoplasmic reticulum. Mitochondrial change did not track liver-function test abnormalities. See Birth control, Liver, Estrogen.

Autism spectrum

Children with autism show a high rate of mitochondrial biomarker abnormalities and an estimated about 5% prevalence of defined mitochondrial disease (versus about 0.01% generally). Lymphocyte work found lower NADH oxidase, frequent complex I activity below the control range, higher pyruvate, lower pyruvate dehydrogenase, and higher mitochondrial hydrogen peroxide production than typically developing controls. Detail and developmental context: Autism.

Chronic stress and the brain

Stress damages the energy producing systems of cells, especially the aerobic mitochondria, in many ways, and this damage can often be repaired.

— Ray Peat

In adult male rats restrained for six hours a day over 21 days, the first complexes of the respiratory chain in brain cortex lost 69% (complex I-III) and 67% (complex II-III) of their activity, alongside glutathione depletion and lipid peroxidation. Complex IV activity, ATP production, and oxygen consumption had not yet changed at 21 days. A blocker of inducible nitric oxide synthase, given from day 7, prevented the complex inhibition, the glutathione loss, and the peroxidation. After 40 days of chronic mild stress, a rat model of depression, complexes I, III, and IV were inhibited in cerebral cortex and cerebellum, while complex II and creatine kinase were unchanged.

Glucocorticoids act on the same machinery along an inverted U. In cultured cortical neurons, long-term low-dose corticosterone raised mitochondrial oxidation, membrane potential, and calcium-holding capacity and protected against a glutamate-like nerve toxin, while high doses lowered these measures and worsened the toxicity. After 3 days, high but not low doses reduced levels of the glucocorticoid receptor and of a cell-survival protein inside mitochondria, and long-term high-dose treatment in vivo lowered that mitochondrial survival protein in prefrontal cortex. See Cortisol.

A 2016 review by Yunnan University and NIMH authors joins these animal findings into one model for depression, PTSD, and suicidal behavior: chronic stress and sleep loss raise cortisol, oxidative load, and homocysteine, which damage neuronal mitochondria and membrane lipids and disturb transmitter signaling. The model rests mostly on rodent and cell data, and the authors call for controlled prevention and treatment trials.

ATP

ATP (adenosine triphosphate) is the cell's usable phosphate energy currency. Mitochondria produce most ATP by oxidizing fuel, chiefly Glucose, with oxygen.

Metabolic health tracks mitochondrial efficiency: ATP and CO₂ per unit fuel, not supplement stacks sold to "boost" ATP.

PTH (like estrogen and serotonin) inhibits cellular respiration and activates glycolysis, lowering the ATP level and shifting the cells' metabolism toward the production of lactic acid rather than carbon dioxide.

— Ray Peat

Oxidation of sugar is metabolically efficient in many ways, including sparing oxygen consumption. It produces more carbon dioxide than oxidizing fat does, and carbon dioxide has many protective functions, including increasing Krebs cycle activity and inhibiting toxic damage to proteins.

— Ray Peat

Low Thyroid function, excess PUFA, Estrogen, Endotoxin, and Serotonin shift cells toward glycolytic Lactic acid production instead of oxidative ATP. See Mitochondria, Bioenergetics, Thyroid.

How mitochondria make it

The mitochondrial enzyme that makes ATP, F-ATP synthase, is a rotary motor. Its central stalk turns about 100 times a second, each full turn makes three ATP molecules, and in vertebrates the c-ring has eight subunits, so 2.7 protons are needed to make each ATP. The proton gradient that drives it is built by respiration.

Glycolysis and lactate

Fermenting glucose to lactate in the presence of oxygen (aerobic glycolysis) is an inefficient way to generate ATP. The advantage it gives proliferating cells is thought to come from nutrient handling that favors growth over efficient ATP production. See Warburg effect.

Hydrotrope

At physiological millimolar levels (about 5–10 mM), ATP behaves as a biological hydrotrope: it keeps proteins soluble and can both prevent and dissolve protein aggregates, a role distinct from the micromolar ATP needed only as a phosphate-transfer energy currency.

The bond-energy question

The textbook "high-energy phosphate bond" account of ATP is contested. On Gilbert Ling's analysis, cells lack the energetic capacity to maintain all their ion gradients by pumping. This is Ling's position, not the mainstream textbook one.

Carnitine

Carnitine shuttles long-chain fatty acids across the mitochondrial membrane so they can be oxidized for energy. Meat, especially red meat, is the main dietary source; plant food has essentially none. It is sold as an energy and fat-loss supplement, with mixed results in practice.

Peat's critical view

In Ray Peat's framework, carnitine supplementation earns suspicion rather than endorsement. The short-chain fatty acids in coconut oil can bypass the carnitine transport system, and research found added carnitine doing the opposite of what supplement marketing implies:

Mildronate...protects cells against stress partly by opposing the action of carnitine, and comparative studies showed that added carnitine had the opposite effect, promoting the oxidation of unsaturated fats during stress, and increasing oxidative damage to cells.

— Ray Peat

In this framing, carnitine's usefulness depends on what it is helping the body burn. When PUFA is present in tissue, pushing more fatty-acid oxidation with carnitine can mean pushing more PUFA oxidation, which raises oxidative stress rather than lowering it. Short-chain saturated fat (as in coconut oil) reaches mitochondria without needing the carnitine shuttle at all, a practical advantage over carnitine-dependent fat burning.

Heart failure trials

A 2009 JACC Viewpoint reviews L-carnitine and propionyl-L-carnitine trials in heart failure (often small, mixed end points) and notes myocardial carnitine deficiency in the failing heart. In 80 patients with dilated cardiomyopathy and NYHA III–IV heart failure randomized to oral L-carnitine 2 g/day or placebo, Kaplan–Meier survival favored L-carnitine over a mean 33.7 ± 11.8 months of follow-up; at analysis there were 6 deaths in the placebo group and 1 in the L-carnitine group among the 70 patients still in the study.

Practical Q&A

Asked whether a diet built around potatoes and mushrooms, without muscle meat, could still supply enough carnitine (along with carnosine, creatine, and taurine, none of which come from plant food), Peat answered:

I think so.

— Ray Peat

Coenzyme Q10

Coenzyme Q10 molecular structure

Coenzyme Q10 (ubiquinone/ubiquinol) shuttles electrons in the mitochondrial respiratory chain and acts as a fat-soluble antioxidant in membranes.

Peat's view

Peat grouped coenzyme Q10 with vitamin K, short-chain fatty acids, ketoacids, niacinamide, and glycine as substances the body always has some of but needs in larger amounts during stress, improving stress resistance when increased. Thyroid and good oxidation build the machinery that uses Q10. Supplemental Q10 is popular for statin users and heart failure contexts, but fixing PUFA load and thyroid status matters more. Food sources include organ meats.

Heart failure

A 2009 JACC Viewpoint reviews mixed CoQ10 trials in heart failure (serum and tissue CoQ10 often low; meta-analyses favorable; several small null studies), and calls for larger outcome trials. In a 1-year double-blind multicenter trial in NYHA III–IV congestive heart failure, CoQ10 at 2 mg/kg/day cut hospitalizations for worsening heart failure (73 of 319 versus 118 of 322 on placebo) and cut episodes of pulmonary edema. A later double-blind trial in 46 completers with class III–IV heart failure found that 200 mg/day CoQ10 raised serum CoQ10 but did not change ejection fraction, peak oxygen consumption, or exercise duration.

In the Q-SYMBIO randomized double-blind trial (420 patients with moderate-to-severe chronic heart failure, 300 mg/day CoQ10 for 2 years on top of standard therapy), CoQ10 lowered cardiovascular mortality by 43.8% (9% vs 16%), all-cause mortality by 44.4% (10% vs 18%), and major adverse cardiovascular events by 42.3% (15% vs 26%) versus placebo.

Fatigue

A 2019 systematic review of interventional studies found that 10 of 16 trials meeting inclusion criteria showed statistically significant reductions in fatigue from CoQ10 supplementation. The benefit was strongest in statin-related fatigue and fibromyalgia, with weaker or inconsistent results in the other populations studied (healthy subjects, multiple sclerosis, and end-stage heart failure). The review did not test chronic fatigue syndrome specifically.

Cytochrome oxidase

Cytochrome oxidase (complex IV) is the mitochondrial enzyme that hands electrons to oxygen at the end of respiration. It is the point where oxygen becomes water and energy chemistry completes. Blue light inhibits it; red light restores it in the cited work. Red and orange light penetrate tissue because water absorbs them weakly, so they can activate the enzyme and raise ATP.

the inhibition of respiratory enzymes by blue light, and their activation by red light.

— Ray Peat

Red and orange wavelengths penetrate tissue very effectively, because of their weaker absorption by water, allowing them to react with pigments in the cell, such as cytochrome oxidase, which is activated (or re-activated) by red light, increasing the production of ATP.

— Ray Peat

Copper and energy

Copper is required for cytochrome oxidase. Copper deficiency and iron excess both undermine oxygen use. See Copper, Iron, Mitochondria, Red light.

Long darkness damages the enzyme in animal work. Day light and red light support recovery. See Light, Red light. A small randomized, sham-controlled human trial tested this mechanism directly in 48 veterans with Gulf War Illness: 15 half-hour sessions of transcranial red/near-infrared light over 7.5 weeks improved working memory versus sham, with further gains at one month in those who scored below average at entry, while the sham group's scores drifted back down; the study was underpowered (n=48) and most other measured outcomes did not reach significance.

Practice

Support copper status, day light, thyroid, and sugar oxidation. Red-light tools are secondary.

Uncoupling (DNP)

2,4-Dinitrophenol, usually shortened to DNP, is an industrial chemical that was sold as a weight-loss drug in the United States in the early 1930s before being banned by the FDA in 1938 after a string of deaths. It has resurfaced periodically since then, most recently as an underground bodybuilding and weight-loss aid bought online, and it remains one of the more dangerous substances people take intentionally, because the difference between a dose that raises metabolism and a dose that kills is small and hard to predict from body weight alone.

Methylene blue dosing

There is no medically established safe dose. Doses used historically and in underground bodybuilding circles have ranged from roughly 200 mg to 400 mg per day, but deaths have occurred within that same range, and the FDA banned it specifically because no dose could be shown to be reliably safe.

Structure/Chemical properties

DNP is a nitrophenol, a benzene ring with two nitro groups and a hydroxyl group attached. It is a weak acid, and this acidity is what lets it do its work inside the cell: it can pick up a proton on one side of the mitochondrial inner membrane, cross the membrane, and drop the proton off on the other side.

Function/Mechanism of Action

Mitochondria normally use the energy from the proton gradient they generate to make ATP, feeding hydrogen ions back through ATP synthase. DNP, being able to shuttle across the membrane in both protonated and deprotonated form, gives protons a way to leak back across without going through ATP synthase. This is called uncoupling: oxygen consumption and fuel burning stay high, or even increase, but less of that energy turns into ATP and more of it is released as heat. In Gilbert Ling's work on mitochondria, DNP also caused a loss of potassium and gain of hydrogen ions in respiring mitochondria. DNP appears to displace K+ in favor of H+ at binding sites that normally regulate the mitochondrion's ion balance.

A 2015 in vitro study comparing DNP to caffeine in muscle cells found that both substances raised PGC-1α expression and increased mitochondrial content along with total oxidative metabolism, by essentially the same pathway, differing mainly in potency and safety margin. Aspirin and thyroid (T3) increase uncoupling in the same way, and DNP, "surprisingly," shares some of their beneficial effects: it stimulates the consumption of lactic acid and the formation of carbon dioxide.

Medical uses/Effects

DNP was marketed and used as a weight-loss drug in the 1930s on the strength of its uncoupling effect: it reliably raises metabolic rate and body temperature, and people taking it lose fat. It has no current approved medical use anywhere. Because chronically raising metabolism this way also raises body temperature, DNP belongs to a group of substances including thyroid, aspirin, salt, and caffeine that reliably raise body temperature, which he linked to lifting the low-metabolism state associated with depression.

Side/Adverse effects

The central danger of DNP is hyperthermia: because it uncouples ATP production from fuel oxidation, the body keeps burning fuel to try to meet its energy demand, and the "wasted" energy comes out as heat with no negative feedback loop to stop it once the dose is high enough. Reported deaths have involved body temperatures well above 40°C, alongside profuse sweating, tachycardia, and multi-organ failure. There is no specific antidote; treatment is supportive cooling. Because the effective dose and the lethal dose are close together, and because DNP accumulates and has a long, unpredictable half-life that varies between individuals, repeated "small" doses can add up to a fatal one without warning.

DNP's toxicity was known from early in the 20th century, but a wave of DNP-induced cataracts in the spring of 1935, probably caused by a product sold at a higher dose, gave the newly formed FDA the outbreak it used to justify expanded regulatory powers. The cataracts appear within hours or days of taking the drug and can resolve spontaneously once it is stopped, faster with Vitamin C supplementation. Estrogens and glucocorticoids also produce permanent cataracts, but have never prompted comparable FDA action.

DNP brands and sources

DNP is not manufactured as a pharmaceutical. It is sold as an industrial chemical (used in dyes, wood preservatives, and explosives manufacture) and is diverted to the underground weight-loss and bodybuilding market, frequently through unregulated online sellers, without quality control on purity or dosing.

Methylene blue

Ray Peat Wiki}} Methylene blue is a synthetic dye with a long history of medical use (as an antimalarial and for methemoglobinemia) that also acts as a redox catalyst supporting mitochondrial electron transport at very low doses.

Dosing

Quite a few people are having very powerful antidepressant effects from it with just one milligram a day. But I think it's probably going to be effective at doses analogous to thyroid hormone. 20, 30, 40 micrograms per day, I think might be the optimal dose of methylene blue.

— Ray Peat

For acquired methemoglobinemia, the US label gives 1 mg/kg intravenously over 5 to 30 minutes, with one repeat dose after an hour if levels stay high. The microgram doses above are a tiny fraction of that clinical dose.

Structure / Chemical properties

Methylene blue (C₁₆H₁₈ClN₃S, 319.9 g/mol) is a phenothiazine dye: a three-ring molecule carrying two dimethylamino groups, sold as the chloride salt and dissolving readily in water.

Swallowed in water, about 72% of a dose reaches the blood. In the body most of it is reduced to colorless leucomethylene blue and leaves mainly in the urine, and its half-life is about a day.

Function / Mechanism of action

After 100 mg doses in seven volunteers, oral methylene blue reached much lower whole-blood levels than intravenous dosing, while in rats oral delivery left more in the intestinal wall and liver and less in blood and brain.

It works as a catalyst for energy production, and I think it can be very effective even in small doses analogous to the effects of thyroid hormone. I suspect that one milligram continues to have good effects for about a week.

— Ray Peat

Methylene blue accepts electrons from NADH and hands them to cytochrome c, so it can carry electrons around blocked or damaged parts of the respiratory chain.

It directly blocks the enzyme that makes nitric oxide, and it does so at lower concentrations than it blocks the downstream guanylyl cyclase it was long assumed to target. In glioblastoma cells it raised oxygen use, cut lactate production and slowed growth, reversing the Warburg pattern; in mice carrying these tumors, once-daily dosing did not shrink them.

Medical uses / Effects

In a randomized blinded rat study of mild traumatic brain injury, methylene blue after injury shrank MRI lesion volume, improved forelimb tests, and reduced neuronal degeneration at 14 days.

The US approved use is treatment of acquired methemoglobinemia in children and adults, where methylene blue converts oxidized hemoglobin back to the oxygen-carrying form. It was the first synthetic antimalarial, and in modern trials, mostly in African children, it cleared malaria reliably and sharply cut the parasite stage that spreads the disease. Because it blocks nitric oxide production, it is also given in septic shock; in a randomized trial, starting it early got patients off blood-pressure drugs about a day sooner.

People have told me that half a milligram stopped their depression.

— Ray Peat

In a randomized placebo-controlled trial in healthy adults, one low oral dose increased brain activity during attention and memory tasks and slightly improved memory recall an hour later. In rats whose mitochondria were partly poisoned, 1 mg/kg given after training fully restored spatial memory.

In rats given estrogen, methylene blue raised dopamine in the pituitary and partly blocked the estrogen-driven pituitary growth and prolactin rise. Given alone in food, it raised blood thyroxine. In mice on a high-fat diet, it prevented fatty liver and liver inflammation while raising the liver's NAD+/NADH ratio and oxygen use. In cultured human skin cells, including cells from people with progeria, it slowed cell aging and spurred growth better than other antioxidants tested.

Side / Adverse effects

In iron overload, methylene blue, like ascorbic acid, can reduce ferric iron to the ferrous form, which creates the most toxic free radicals.

Methylene blue is a potent reversible inhibitor of monoamine oxidase A. The US injection label carries a boxed warning for serotonin syndrome, sometimes fatal, when combined with serotonergic antidepressants, MAO inhibitors or opioids, and it rules out use in G6PD deficiency because of the risk of hemolytic anemia. Headache, nausea, diarrhea and low potassium or magnesium were the most common reactions at intravenous doses.

Brands and sources

The prescription injection is sold in the US as ProvayBlue (5 mg/mL). Methylene blue began as a textile dye and is still widely used as a biological stain in histology, bacteriology and hematology. The US injection is labeled USP grade.

Per its bottle label, the liquid below supplies about 400 mcg of methylene blue USP per drop together with 400 mcg caffeine and 40 mcg benzoic acid in 20% ethanol, with about 240 drops per bottle.

Oxidal (Idea Labs)$24.99

NAD+

NAD+ and NADH are redox cofactors. NAD+ accepts electrons; NADH donates them into the respiratory chain.

Mitochondrial energy view

Thyroid-driven oxygen consumption keeps NAD+ concentration hundreds of times higher than NADH, preventing lactic acid production and toxic redox cycling. Elsewhere Peat put a specific figure on this ratio in a healthy oxidized cell, about 200 to 1. Niacinamide and dietary B3 support NAD pools. Fashionable NAD-IV and precursor marketing outruns solid lifestyle basics: sleep, food, thyroid, low PUFA. Measure function (temperature, pulse, labs) over boutique assays alone.

NAD/NADH ratio and pyruvate dehydrogenase

Pyruvate dehydrogenase (PDH) activity, the rate-limiting gate from glycolysis into the Krebs cycle, depends on a favorable NAD/NADH ratio plus thiamine and magnesium as cofactors. When PDH is downregulated, as in hypothyroidism and cancer metabolism, pyruvate and NADH accumulate; the body then oxidizes that excess NADH back to NAD+ using pyruvate itself as the oxidant (via LDH), generating lactate even when oxygen is present. Raising niacinamide intake expands the total NAD+NADH pool and can restore PDH activity through the NAD/NADH ratio; quinone-type oxidants such as vitamin K2, emodin, and methylene blue achieve the same effect by directly re-oxidizing NADH to NAD+ without adding to the pool, letting PDH resume even under cancer-like excess-glycolysis conditions. Biotin offers a parallel route: it activates pyruvate decarboxylase, an alternative enzyme that shares PDH's thiamine/magnesium cofactor requirement and lets accumulated pyruvate reach the Krebs cycle when PDH itself is impaired. Methylene blue additionally lets electrons bypass a blocked complex I-III and can activate complex IV (cytochrome c oxidase) directly, alongside thyroid (T3) and progesterone as the most effective pro-metabolic agents in this scheme, with DHEA, niacinamide, pregnenolone, and magnesium next.

Oxidative phosphorylation

Oxidative phosphorylation couples electron transport to ATP synthesis in mitochondria. Oxygen is the final electron acceptor; CO2 is a product of upstream fuel oxidation.

What impairs it

In ischemic brain tissue, mitochondria show impaired oxidative phosphorylation alongside accumulation of free fatty acids that act as an uncoupling factor, linking energy failure directly to fatty-acid release under stress. Anything that uncouples respiration, blocks cytochromes, or loads membranes with unstable PUFA lowers the quality of this process.

Uncoupling

Mitochondrial uncoupling is respiration that produces heat instead of maximum ATP. Some uncoupling is adaptive warmth and safety valve. Pathological uncoupling under stress and free fatty acid load wastes energy without useful work.

Adaptive vs wasteful

Healthy thyroid-driven metabolism includes controlled heat. Stress, PUFA free fatty acids, and low CO2 push inefficient paths with more lactic acid and less useful work. The goal is oxidative efficiency with adequate heat, not cold, throttled metabolism.

Cytochrome oxidase practice

Raise useful oxidation with thyroid support, sugar, and lower PUFA. Do not chase "uncoupling supplements" as a fat-loss stunt: 2,4-dinitrophenol (DNP), an industrial chemical illicitly sold as a weight-loss aid specifically because it forces mitochondrial uncoupling, has caused documented deaths at blood concentrations as low as 28-36.1 mg/L, with fatal cases sharing markedly elevated body temperature and rapid pulse and breathing, the same "hot and racing" pattern this page warns against when uncoupling runs unchecked.

See also

• Metabolism
• Statins
• Vitamin E
• B vitamins
• Oxidative stress
• Bioenergetics
• Tissue leakiness
• Hair loss: dermal papilla cells are among the fastest-dividing, most ATP-hungry cells in the body; mitochondrial dysfunction there is directly implicated in androgenetic alopecia